Primo PR. Given the recent run-up based on the anticipation of the Lipo-Laser being approved, revenues from another source (an huge revenues at that) should really put the Dafster on the map, eh?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.